We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$140B
AUM Growth
+$8.82B
Cap. Flow
+$6.45B
Cap. Flow %
4.62%
Top 10 Hldgs %
43.14%
Holding
4,144
New
234
Increased
2,456
Reduced
1,097
Closed
250

Sector Composition

Rank Sector Weight
1 Technology 8.41%
2 Financials 3.9%
3 Consumer Discretionary 2.18%
4 Healthcare 2.1%
5 Communication Services 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKI icon
3701
Invesco Advantage Municipal Income Trust II
VKI
$394M
$108K ﹤0.01%
11,793
-3,999
-25% -$35.5K
WB icon
3702
Weibo
WB
$1.9B
$107K ﹤0.01%
10,506
+99
+1% +$1.06K
YEXT icon
3703
Yext
YEXT
$501M
$106K ﹤0.01%
13,156
-3,495
-21% -$29.4K
ATAI icon
3704
AtaiBeckley Inc
ATAI
$2.66B
$105K ﹤0.01%
25,760
CRDF icon
3705
Cardiff Oncology
CRDF
$64.3M
$105K ﹤0.01%
37,454
-2,648
-7% -$6.15K
GHI icon
3706
Greystone Housing Impact Investors LP
GHI
$118M
$105K ﹤0.01%
15,229
CHPT icon
3707
ChargePoint
CHPT
$133M
$104K ﹤0.01%
+15,696
New +$148K
XNET
3708
Xunlei
XNET
$351M
$104K ﹤0.01%
+14,674
New +$118K
GGN
3709
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$104K ﹤0.01%
20,136
+6,205
+45% +$31.2K
ASM
3710
Avino Silver & Gold Mines
ASM
$987M
$104K ﹤0.01%
16,724
+3,850
+30% +$20.7K
ZVRA icon
3711
Zevra Therapeutics
ZVRA
$563M
$103K ﹤0.01%
11,544
-1,529
-12% -$14.5K
AOD
3712
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
$103K ﹤0.01%
10,578
-250
-2% -$2.4K
LXEO icon
3713
Lexeo Therapeutics
LXEO
$366M
$103K ﹤0.01%
+10,358
New +$94.5K
FTMU
3714
Franklin Municipal Income ETF
FTMU
$494M
$102K ﹤0.01%
+13,106
New +$103K
MBI icon
3715
MBIA
MBI
$288M
$102K ﹤0.01%
14,300
+2,305
+19% +$16.7K
ESRT icon
3716
Empire State Realty Trust
ESRT
$976M
$101K ﹤0.01%
15,465
-7,519
-33% -$53.7K
HNST icon
3717
The Honest Company
HNST
$417M
$100K ﹤0.01%
38,919
-2,297
-6% -$7.04K
VNET
3718
VNET Group
VNET
$2.05B
$97.6K ﹤0.01%
11,531
-1,513
-12% -$14K
CEFZ
3719
RiverNorth Active Income ETF
CEFZ
$39.4M
$97.3K ﹤0.01%
11,876
SRTA
3720
Strata Critical Medical Inc
SRTA
$436M
$96.4K ﹤0.01%
+20,041
New +$96.9K
SWIM icon
3721
Latham Group
SWIM
$646M
$95.2K ﹤0.01%
14,989
-2,613
-15% -$18.3K
EGHT icon
3722
8x8 Inc
EGHT
$247M
$94.7K ﹤0.01%
48,077
+6,559
+16% +$12.9K
KOPN icon
3723
Kopin
KOPN
$663M
$94.2K ﹤0.01%
40,261
+18,450
+85% +$53.3K
CERT icon
3724
Certara
CERT
$1.17B
$93.8K ﹤0.01%
10,647
-66
-0.6% -$680
RPAY icon
3725
Repay Holdings
RPAY
$315M
$91.9K ﹤0.01%
25,179
-60,405
-71% -$242K

Similar funds

Creative Planning's Q4 2025 Portfolio in Review

As of Q4 2025, Creative Planning held 4,144 positions worth $140B, up 6.7% from $131B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Creative Planning deployed $6.45B of net new capital in Q4 2025, opening 234 new positions and adding to 2,456 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 352,181 shares worth $21.5M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $533M trimmed.

  • Creative Planning's largest Q4 2025 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 352,181 shares worth $21.5M.
  • Creative Planning added most to Vanguard Short-Term Bond ETF in Q4 2025, an estimated $2.02B increase.
  • Creative Planning's biggest Q4 2025 reduction was Vanguard Total Bond Market, cutting an estimated $533M.
  • Creative Planning fully exited Mr. Cooper in Q4 2025, selling an estimated $8.98M.
  • Creative Planning's ten largest holdings make up 43% of its $140B portfolio in Q4 2025.
  • Creative Planning opened 234 new positions and closed 250 in Q4 2025.
  • Creative Planning's portfolio value rose 6.7% quarter-over-quarter to $140B.

Based on Creative Planning's 13F filing for Q4 2025, filed 17 Feb 2026.